Abstract Search

ea0073aep95 | Calcium and Bone | ECE2021

High dose short term glucocorticoid (gc) treatment seems to have no long term negative effect on bone mineral density (bmd) of newly diagnosed multiple sclerosis (ms) patients

Simeakis George , Saltiki Katerina , Fakas Nikolaos , Koutsikos John , Athanasiou Kostas , Papatheodorou George , Papatheodorou Athanasios , Zapanti Evangelia , Anagnostouli Maria , Alevizaki Maria , Terpos Evangelos

ObjectivesHigh-Dose-Intravenous-Steroid-Treatment-(HDIST) represents the first choice of treatment for MS relapses. Although chronic oral GC-administration is associated with bone loss there are still conflicting data regarding HDIST. Methods25 newly-diagnosed MS-patients (10-women) were prospectively enrolled meeting the following eligibility criteria: age 1845 yrs, fully ambulatory, women with normal ...

0 shares

Endocrine Abstracts

High dose short term glucocorticoid (gc) treatment seems to have no long term negative effect on bone mineral density (bmd) of newly diagnosed multiple sclerosis (ms) patients

BiosciAbstracts